Twin-twin transfusion syndrome (TTTS) procedure outcomes
TTTS + MWFCC
The Midwest Fetal Care Center (MWFCC) performed its first fetoscopic laser ablation (FLA) for twin-twin transfusion syndrome (TTTS) in 2008. Led by a team of top medical experts in the field of maternal-fetal medicine and fetal diagnosis and therapy, our program has become one of the highest volume treatment centers for TTTS in the nation and has exceptional outcomes.
Our center performed 100 laser surgeries between July 1, 2017, and Aug. 31, 2020, with 92 delivered and 8 ongoing pregnancies.
A summary of Midwest Fetal Care Center’s current clinical outcomes data for the treatment of TTTS is presented here. Our goal is to provide our patients and community the latest TTTS patient outcomes data to support informed decision-making.
We are actively involved in research regarding TTTS and collaborate with other advanced fetal care centers in the U.S. and internationally through the North American Fetal Therapy network (NAFTnet) and the International Fetal Medicine Surgery Society (IFMSS). We submit patient data (with informed consent) to a multi-center collaborative registry hosted by NAFTnet to investigate outcomes of this procedure with the goal of advancing care of families affected by TTTS.
TTTS stage at presentation
- Stage I (%)
- Stage II (%)
- Stage III (%)
- Stage IV (%)
Gestational age at time of FLA
- 16-18 weeks (%)
- 19-21 weeks (%)
- 22-24 weeks (%)
- 25-27 weeks (%)
- 28+ weeks (%)
Average estimated gestational age at FLA: 20 weeks, 3 days
Average estimated gestational age at delivery: 30 weeks, 5 days
Data measured July 1, 2017 – Aug. 31, 2020
Neonatal survival after TTTS fetal procedure
FLA 159 out of 189 total babies delivered
- 2 survivors (%)
- 1 survivor (%)
- 0 survivors (%)
Includes 5 triplet cases: 4 cases with 3 survivors, 1 case with 2 survivors
30-day post-delivery NICU survival rate by TTTS stage
|TTTS Stage||2 survivors||1 survivor||0 survivors|
Data measured July 1, 2017 – Sept. 30, 2020